副鼻腔がんの世界市場レポート 2025年

副鼻腔がん市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.7％で14億4,000万米ドルに成長します。予測期間の成長は、免疫療法の需要拡大、ヘルスケア支出の増加、個別化医療の開発、規制当局の支援と希少疾病用医薬品の指定、高齢者の拡大などに起因しています。予測期間における主要動向としては、がん診断におけるAIの採用、遺伝子治療や標的薬の進歩、低侵襲手術の拡大、リキッドバイオプシーの役割の台頭、遠隔医療やデジタルヘルスツールの利用の増加などが挙げられます。

タバコの使用量の増加は、今後数年間の副鼻腔がん市場の拡大を牽引すると予想されます。タバコの消費には、タバコ、葉巻、無煙タバコなどさまざまな製品が含まれ、いずれも個人を複数の発がん性物質にさらします。タバコ使用の増加は、世界の喫煙率の増加、タバコ会社による積極的なマーケティング、社会経済的課題、低・中所得国における規制強化の弱さ、特定地域における文化的受容などの要因に影響されています。喫煙は粘膜を傷つけ、腫瘍の成長を促進する有害な化学品をもたらすため、タバコの使用率の増加は副鼻腔がんのリスクを高めています。タバコの煙に含まれる発がん物質は、細胞の突然変異や炎症を引き起こし、副鼻腔のがんリスクをさらに高めています。例えば、2024年9月、米国の政府機関である疾病対策予防センター（CDC）は、2022年に人口の19.8％にあたる約4,920万人の米国成人がタバコ製品を使用したと報告しました。その結果、タバコ消費量の増加が副鼻腔がん市場の成長に拍車をかけています。

腫瘍学の調査と医療への投資の増加も、副鼻腔がん市場の拡大に寄与すると予想されます。これらの投資は、政府、製薬会社、研究機関、非公開投資家によって行われ、がんの理解、予防、診断、治療の向上を目指しています。がん研究費の増加は、世界のがん罹患率の増加、精密医療の進歩、革新的な治療法に対する需要の増加、臨床検査の拡大、政府や民間の資金提供イニシアティブ、標的療法や免疫療法の研究開発によってもたらされています。このような投資は、早期診断の改善、標的療法や免疫療法などの治療選択肢の強化、より効果的な薬剤の臨床検査への資金提供、小児がん治療のインフラ強化、疾患の生物学的性質や進行についてより深い洞察を得るための研究促進などにより、副鼻腔がんの進歩を支えています。例えば、2024年5月、先進的分析を専門とするインドの情報技術企業IQVIAは、がん医療に対する世界の支出は2023年に2,230億米ドルに上り、2022年から250億米ドル増加し、2028年には4,090億米ドルに達すると予測していると報告しました。その結果、がん研究・医療への投資の増加が副鼻腔がん市場の成長を加速させています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の副鼻腔がんPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の副鼻腔がん市場：成長率分析
• 世界の副鼻腔がん市場の実績：規模と成長、2019～2024年
• 世界の副鼻腔がん市場の予測：規模と成長、2024～2029年、2034年
• 世界の副鼻腔がん総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の副鼻腔がん市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 扁平上皮がん
• 腺がん
• 粘表皮がん
• その他
• 世界の副鼻腔がん市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
• 病歴と身体検査
• 画像検査
• 生検
• その他
• 世界の副鼻腔がん市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 手術
• 放射線治療
• 化学療法
• 標的療法
• 免疫療法
• 世界の副鼻腔がん市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院とクリニック
• がん治療研究センター
• ラボ
• その他
• 世界の副鼻腔がん市場、扁平上皮がんのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 角化扁平上皮がん
• 非角化扁平上皮がん
• 基底核扁平上皮がん
• 世界の副鼻腔がん市場、腺がんのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 腸型腺がん
• 非腸管型腺がん
• 世界の副鼻腔がん市場、粘表皮がんのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 低悪性度粘表皮がん
• 中悪性度粘表皮がん
• 高悪性度粘表皮がん
• 世界の副鼻腔がん市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 副鼻腔未分化がん
• 神経内分泌がん
• 腺様嚢胞がん
• 黒色腫
• 肉腫
• リンパ腫

第7章 地域別・国別分析

• 世界の副鼻腔がん市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の副鼻腔がん市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 副鼻腔がん市場：競合情勢
• 副鼻腔がん市場：企業プロファイル
  • Bristol-Myers Squibb
  • Penn Medicine
  • MD Anderson Cancer Center
  • RWJBarnabas Health
  • Mayo Foundation for Medical Education and Research

第31章 その他の大手企業と革新的企業

• Stanford Health Care
• Memorial Sloan Kettering Cancer Center
• Massachusetts General Hospital
• The University of Chicago Medical Center
• City of Hope
• Moffitt Cancer Center
• Northwestern Medicine
• UK Markey Cancer Center
• Karmanos Cancer Institute
• Dana-Farber Cancer Institute Inc.
• VCU Massey Cancer Center
• Vanderbilt-Ingram Cancer Center
• Fulgent Pharma
• Duke University Health System
• Montefiore Einstein Comprehensive Cancer Center

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 副鼻腔がん市場、2029年：新たな機会を提供する国
• 副鼻腔がん市場、2029年：新たな機会を提供するセグメント
• 副鼻腔がん市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Paranasal sinus cancer is a rare malignancy that originates in the air-filled cavities surrounding the nose. The primary goal of managing this cancer is early identification, diagnosis, and treatment to improve survival rates and enhance the patient's quality of life. Treatment focuses on eliminating or shrinking the tumor, preventing its spread, and alleviating symptoms such as pain and nasal blockage.

The main types of paranasal sinus cancer include squamous cell carcinoma, adenocarcinoma, mucoepidermoid carcinoma, and others. Squamous cell carcinoma arises from the squamous cells in the sinuses, often leading to nasal obstruction, pain, and other localized symptoms. Diagnosis involves medical history evaluation, physical examination, imaging tests, and biopsy. Treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. These treatments are utilized by various end-users, including hospitals and clinics, cancer treatment and research centers, and research laboratories.

The paranasal sinus cancer market research report is one of a series of new reports from The Business Research Company that provides paranasal sinus cancer market statistics, including the paranasal sinus cancer industry global market size, regional shares, competitors with the paranasal sinus cancer market share, detailed paranasal sinus cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the paranasal sinus cancer industry. This personal emergency response system (PERS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The paranasal sinus cancer market size has grown strongly in recent years. It will grow from $1.03 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to advancements in radiation therapy, increasing awareness and early diagnosis, the expanding use of chemotherapy and targeted therapy, improved surgical techniques, and a rising incidence of occupational exposure-linked cases.

The paranasal sinus cancer market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to the growing demand for immunotherapy, rising healthcare expenditure, the development of personalized medicine, regulatory support and orphan drug designations, and an expanding geriatric population. Major trends in the forecast period include the adoption of AI in cancer diagnosis, advancements in gene therapy and targeted drugs, the expansion of minimally invasive surgeries, the emerging role of liquid biopsies, and the increasing use of telemedicine and digital health tools.

The increasing use of tobacco is expected to drive the expansion of the paranasal sinus cancer market in the coming years. Tobacco consumption includes various products such as cigarettes, cigars, and smokeless tobacco, all of which expose individuals to multiple carcinogens. The rise in tobacco use is influenced by factors such as increasing global smoking rates, aggressive marketing by tobacco companies, socio-economic challenges, weak regulatory enforcement in low- and middle-income countries, and cultural acceptance in certain regions. The growing prevalence of tobacco use raises the risk of paranasal sinus cancer, as smoking introduces harmful chemicals that damage mucous membranes and encourage tumor growth. Carcinogens in tobacco smoke contribute to cellular mutations and inflammation, further increasing cancer risk in the sinuses. For example, in September 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that approximately 49.2 million U.S. adults, or 19.8% of the population, used tobacco products in 2022. As a result, the rising tobacco consumption is fueling the growth of the paranasal sinus cancer market.

Increasing investments in oncology research and medicine are also expected to contribute to the expansion of the paranasal sinus cancer market. These investments, made by governments, pharmaceutical companies, research institutions, and private investors, aim to advance the understanding, prevention, diagnosis, and treatment of cancer. The rise in oncology research funding is driven by the growing global cancer burden, advancements in precision medicine, increasing demand for innovative therapies, expansion of clinical trials, government and private funding initiatives, and the development of targeted and immunotherapy treatments. Such investments support progress in paranasal sinus cancer by improving early diagnosis, enhancing treatment options such as targeted therapies and immunotherapy, funding clinical trials for more effective drugs, strengthening pediatric cancer care infrastructure, and fostering research to gain deeper insights into the disease's biology and progression. For instance, in May 2024, IQVIA, an India-based information technology company specializing in advanced analytics, reported that global spending on cancer medicine rose to $223 billion in 2023, a $25 billion increase from 2022, and is projected to reach $409 billion by 2028. Consequently, increasing investments in oncology research and medicine are accelerating the growth of the paranasal sinus cancer market.

The rise in clinical trials is key factor driving the expansion of the paranasal sinus cancer market. Clinical trials are research studies conducted to assess the safety, effectiveness, and potential benefits of new treatments or therapies in humans. The growing number of clinical trials is driven by advancements in medical research, the demand for innovative treatments, the increasing prevalence of chronic diseases, regulatory support, and expanding investments in biotechnology and pharmaceutical industries. The surge in clinical trials for paranasal sinus cancer accelerates the development of improved treatments, enhances understanding of the disease, and evaluates innovative therapies. This contributes to better patient outcomes, reduced side effects, and advancements in cancer care. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the total number of industry-sponsored clinical trials launched in the UK increased by 4.3%, from 394 trials in 2021 to 411 in 2022. As a result, the growing number of clinical trials is driving the advancement of the paranasal sinus cancer market.

Major players in the paranasal sinus cancer market are Bristol-Myers Squibb, Penn Medicine, MD Anderson Cancer Center, RWJBarnabas Health, Mayo Foundation for Medical Education and Research, Stanford Health Care, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, The University of Chicago Medical Center, City of Hope, Moffitt Cancer Center, Northwestern Medicine, UK Markey Cancer Center, Karmanos Cancer Institute, Dana-Farber Cancer Institute Inc., VCU Massey Cancer Center, Vanderbilt-Ingram Cancer Center, Fulgent Pharma, Duke University Health System, Montefiore Einstein Comprehensive Cancer Center.

North America was the largest region in the paranasal sinus cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in paranasal sinus cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the paranasal sinus cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The paranasal sinus cancer market consists of revenues earned by entities providing services such as palliative and supportive care, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The paranasal sinus cancer market also includes sales of chemotherapy agents, radiopharmaceuticals, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Paranasal Sinus Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on paranasal sinus cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for paranasal sinus cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The paranasal sinus cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Squamous Cell Carcinoma; Adenocarcinoma; Mucoepidermoid Carcinoma; Other Types
• 2) By Diagnosis: Medical History And Physical Examination; Imaging Tests; Biopsy; Other Diagnosis
• 3) By Treatment: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Immunotherapy
• 4) By End-User: Hospital And Clinics; Cancer Treatment And Research Center; Research Laboratories; Other End-Users
• Subsegments:
• 1) By Squamous Cell Carcinoma: Keratinizing Squamous Cell Carcinoma; Non-Keratinizing Squamous Cell Carcinoma; Basaloid Squamous Cell Carcinoma
• 2) By Adenocarcinoma: Intestinal-Type Adenocarcinoma; Non-Intestinal-Type Adenocarcinoma
• 3) By Mucoepidermoid Carcinoma: Low-Grade Mucoepidermoid Carcinoma; Intermediate-Grade Mucoepidermoid Carcinoma; High-Grade Mucoepidermoid Carcinoma
• 4) By Other Types: Sinonasal Undifferentiated Carcinoma; Neuroendocrine Carcinoma; Adenoid Cystic Carcinoma; Melanoma; Sarcomas; Lymphoma
• Companies Mentioned:Bristol-Myers Squibb; Penn Medicine; MD Anderson Cancer Center; RWJBarnabas Health; Mayo Foundation for Medical Education and Research
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Paranasal Sinus Cancer Market Characteristics

3. Paranasal Sinus Cancer Market Trends And Strategies

4. Paranasal Sinus Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Paranasal Sinus Cancer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Paranasal Sinus Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Paranasal Sinus Cancer Market Growth Rate Analysis
• 5.4. Global Paranasal Sinus Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Paranasal Sinus Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Paranasal Sinus Cancer Total Addressable Market (TAM)

6. Paranasal Sinus Cancer Market Segmentation

• 6.1. Global Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Squamous Cell Carcinoma
• Adenocarcinoma
• Mucoepidermoid Carcinoma
• Other Types
• 6.2. Global Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical History And Physical Examination
• Imaging Tests
• Biopsy
• Other Diagnosis
• 6.3. Global Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiation Therapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• 6.4. Global Paranasal Sinus Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital And Clinics
• Cancer Treatment And Research Center
• Research Laboratories
• Other End-Users
• 6.5. Global Paranasal Sinus Cancer Market, Sub-Segmentation Of Squamous Cell Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Keratinizing Squamous Cell Carcinoma
• Non-Keratinizing Squamous Cell Carcinoma
• Basaloid Squamous Cell Carcinoma
• 6.6. Global Paranasal Sinus Cancer Market, Sub-Segmentation Of Adenocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intestinal-Type Adenocarcinoma
• Non-Intestinal-Type Adenocarcinoma
• 6.7. Global Paranasal Sinus Cancer Market, Sub-Segmentation Of Mucoepidermoid Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Grade Mucoepidermoid Carcinoma
• Intermediate-Grade Mucoepidermoid Carcinoma
• High-Grade Mucoepidermoid Carcinoma
• 6.8. Global Paranasal Sinus Cancer Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sinonasal Undifferentiated Carcinoma
• Neuroendocrine Carcinoma
• Adenoid Cystic Carcinoma
• Melanoma
• Sarcomas
• Lymphoma

7. Paranasal Sinus Cancer Market Regional And Country Analysis

• 7.1. Global Paranasal Sinus Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Paranasal Sinus Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Paranasal Sinus Cancer Market

• 8.1. Asia-Pacific Paranasal Sinus Cancer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Paranasal Sinus Cancer Market

• 9.1. China Paranasal Sinus Cancer Market Overview
• 9.2. China Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Paranasal Sinus Cancer Market

• 10.1. India Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Paranasal Sinus Cancer Market

• 11.1. Japan Paranasal Sinus Cancer Market Overview
• 11.2. Japan Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Paranasal Sinus Cancer Market

• 12.1. Australia Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Paranasal Sinus Cancer Market

• 13.1. Indonesia Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Paranasal Sinus Cancer Market

• 14.1. South Korea Paranasal Sinus Cancer Market Overview
• 14.2. South Korea Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Paranasal Sinus Cancer Market

• 15.1. Western Europe Paranasal Sinus Cancer Market Overview
• 15.2. Western Europe Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Paranasal Sinus Cancer Market

• 16.1. UK Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Paranasal Sinus Cancer Market

• 17.1. Germany Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Paranasal Sinus Cancer Market

• 18.1. France Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Paranasal Sinus Cancer Market

• 19.1. Italy Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Paranasal Sinus Cancer Market

• 20.1. Spain Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Paranasal Sinus Cancer Market

• 21.1. Eastern Europe Paranasal Sinus Cancer Market Overview
• 21.2. Eastern Europe Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Paranasal Sinus Cancer Market

• 22.1. Russia Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Paranasal Sinus Cancer Market

• 23.1. North America Paranasal Sinus Cancer Market Overview
• 23.2. North America Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Paranasal Sinus Cancer Market

• 24.1. USA Paranasal Sinus Cancer Market Overview
• 24.2. USA Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Paranasal Sinus Cancer Market

• 25.1. Canada Paranasal Sinus Cancer Market Overview
• 25.2. Canada Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Paranasal Sinus Cancer Market

• 26.1. South America Paranasal Sinus Cancer Market Overview
• 26.2. South America Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Paranasal Sinus Cancer Market

• 27.1. Brazil Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Paranasal Sinus Cancer Market

• 28.1. Middle East Paranasal Sinus Cancer Market Overview
• 28.2. Middle East Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Paranasal Sinus Cancer Market

• 29.1. Africa Paranasal Sinus Cancer Market Overview
• 29.2. Africa Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Paranasal Sinus Cancer Market Competitive Landscape And Company Profiles

• 30.1. Paranasal Sinus Cancer Market Competitive Landscape
• 30.2. Paranasal Sinus Cancer Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. MD Anderson Cancer Center Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. RWJBarnabas Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis

31. Paranasal Sinus Cancer Market Other Major And Innovative Companies

• 31.1. Stanford Health Care
• 31.2. Memorial Sloan Kettering Cancer Center
• 31.3. Massachusetts General Hospital
• 31.4. The University of Chicago Medical Center
• 31.5. City of Hope
• 31.6. Moffitt Cancer Center
• 31.7. Northwestern Medicine
• 31.8. UK Markey Cancer Center
• 31.9. Karmanos Cancer Institute
• 31.10. Dana-Farber Cancer Institute Inc.
• 31.11. VCU Massey Cancer Center
• 31.12. Vanderbilt-Ingram Cancer Center
• 31.13. Fulgent Pharma
• 31.14. Duke University Health System
• 31.15. Montefiore Einstein Comprehensive Cancer Center

32. Global Paranasal Sinus Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Paranasal Sinus Cancer Market

34. Recent Developments In The Paranasal Sinus Cancer Market

35. Paranasal Sinus Cancer Market High Potential Countries, Segments and Strategies

• 35.1 Paranasal Sinus Cancer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Paranasal Sinus Cancer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Paranasal Sinus Cancer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer